Skip to main content

Table 4 Associations* between components of metabolic syndrome and carotid atherosclerosis after 13 years

From: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study

  Follow-up levels Change from baseline to follow-up
  IMT (mm) TPA(mm²) ΔIMT (mm) ΔTPA(mm²)
  β p β p β p β p
Men         
Age 0.008 <0.0001 0.102 <0.0001 - - 0.031 <0.0001
Components of MetS         
Hypertension 0.045 0.0004 0.642 0.0003 - - - -
Abdominal obesity - - - - - - - -
Hypertriglyceridemia 0.029 0.01 - - - - - -
Low HDL-level - - - - - - - -
Impaired glucose tolerance 0.102 0.001 1.129 0.01 0.075 0.006 - -
LDL cholesterol 0.013 0.02 0.263 0.0006 - - - -
Daily smoking 0.04 0.0001 1.134 <0.0001 0.021 0.006 0.516 0.001
Women         
Age 0.008 <0.0001 0.073 <0.0001 0.002 <0.0001 0.027 <0.0001
Components of MetS         
Hypertension 0.041 <0.0001 0.643 <0.0001 - - 0.308 0.02
Abdominal obesity - - - - - - - -
Hypertriglyceridemia 0.026 0.014 - - - - - -
Low HDL-level 0.031 0.012 - - - - - -
Impaired glucose tolerance - - - - - - - -
LDL cholesterol 0.021 <0.0001 0.425 <0.0001 - - 0.195 0.0004
Daily smoking 0.025 0.025 0.956 <0.0001 0.034 0.0008 0.537 <0.0001
  1. * Stepwise multivariable linear regression analysis with forward selection and significance level 0.05 for entry into the model.
  2. †square-root-transformed values were used in the analyses.
  3. ‡p values for β-coefficient.
  4. MetS; metabolic syndrome, HDL; high-density lipoprotein cholesterol, LDL; low-density lipoprotein cholesterol.
  5. The Tromsø Study.